Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Brain Res ; 1751: 147175, 2021 01 15.
Article in English | MEDLINE | ID: mdl-33121921

ABSTRACT

Environmental enrichment (EE) attenuates traumatic brain injury (TBI)-induced loss of medial septal (MS) choline acetyltransferase (ChAT)-cells and enhances spatial learning and memory vs. standard (STD) housing. Whether basal forebrain cholinergic neurons (BFCNs) are important mediators of EE-induced benefits after TBI requires further investigation. Anesthetized female rats were randomly assigned to intraseptal infusions of the immunotoxin 192-IgG-saporin (SAP; 0.22 µg in 1.0 µL) or vehicle (VEH; 1.0 µL IgG) followed immediately by a cortical impact (2.8 mm deformation depth at 4 m/s) or sham injury and divided into EE and STD housing. Spatial learning and memory retention were assessed on post-operative days 14-19. MS ChAT+ cells were quantified at 3 weeks. SAP significantly reduced ChAT+ cells in both the EE and STD groups. Cognitive performance was improved in the EE groups, regardless of VEH or SAP infusion, vs. the STD-housed groups (p's < 0.05). No cognitive differences were revealed between the TBI + EE + SAP and TBI + EE + VEH groups (p > 0.05) or between the TBI + STD + SAP and TBI + STD + VEH groups (p > 0.05). These data show that despite significant MS ChAT+ cell loss, the EE-mediated benefit in cognitive recovery is not compromised.


Subject(s)
Basal Forebrain/metabolism , Cholinergic Neurons/physiology , Cognition/physiology , Animals , Basal Forebrain/physiology , Brain Injuries, Traumatic/physiopathology , Brain Injuries, Traumatic/psychology , Brain Injuries, Traumatic/therapy , Cholinergic Neurons/metabolism , Environment , Female , Maze Learning/physiology , Memory/physiology , Psychomotor Performance/physiology , Rats , Rats, Sprague-Dawley , Spatial Learning/physiology
2.
Restor Neurol Neurosci ; 36(1): 45-57, 2018.
Article in English | MEDLINE | ID: mdl-29439368

ABSTRACT

BACKGROUND: The acetylcholinesterase inhibitor (AChEI) donepezil (DON) is recommended as a potential treatment for cognition after clinical traumatic brain injury (TBI) and therefore may be prescribed as an adjunct therapy during rehabilitation. However, a dose-response study evaluating DON after a controlled cortical impact (CCI) injury in rats did not reveal cognitive benefits. OBJECTIVE: The aim of this study was to determine the effect of DON on behavioral and histological outcome when combined with environmental enrichment (EE), a preclinical model of neurorehabilitation. It was hypothesized that the combined treatments would produce a synergistic effect yielding improved recovery over neurorehabilitation alone. METHODS: Isoflurane-anesthetized adult male rats received a CCI or sham injury and then were randomly assigned to EE or standard (STD) housing plus systemic injections of DON (0.25 mg/kg) or vehicle (VEH; 1.0 mL/kg saline) once daily for 19 days beginning 24 hr after injury. Function was assessed by established motor and cognitive tests on post-injury days 1-5 and 14-19, respectively. Cortical lesion volume was quantified on day 19. RESULTS: DON was ineffective when administered alone. In contrast, EE conferred significant motor and cognitive benefits, and reduced cortical lesion volume vs. STD (p < 0.05). Combining the therapies weakened the efficacy of rehabilitation as revealed by diminished motor and cognitive recovery in the TBI+EE+DON group vs. the TBI+EE+VEH group (p < 0.05). CONCLUSION: These data replicate previous findings showing that EE is beneficial and DON is ineffective after CCI and add to the literature a novel and unpredicted finding that supports neither the hypothesis nor the use of DON for TBI. Investigation of other AChEIs after CCI injury is necessary to gain further insight into the value of this therapeutic strategy.


Subject(s)
Brain Injuries, Traumatic/complications , Cognition Disorders , Environment , Indans/therapeutic use , Mental Disorders , Nootropic Agents/therapeutic use , Piperidines/therapeutic use , Analysis of Variance , Animals , Cerebral Cortex/metabolism , Cerebral Cortex/pathology , Cognition Disorders/drug therapy , Cognition Disorders/etiology , Cognition Disorders/rehabilitation , Disease Models, Animal , Donepezil , Male , Maze Learning/physiology , Mental Disorders/drug therapy , Mental Disorders/etiology , Mental Disorders/rehabilitation , Motor Activity/drug effects , Neurologic Examination , Psychomotor Performance/drug effects , Rats , Rats, Sprague-Dawley , Rotarod Performance Test , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...